FTO and Parkinson disease: A study performed on PD mouse and cell models showed that a high level of FTO reduced the m6A modifications in dopaminergic cells, resulted in the overexpression of NMDA receptor 1 (N-methyl-D-aspartate), oxidative stress, and Ca2+ influx, leading to neuronal damage and neuroinflammation [133].